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Abstract
Background. Alexithymia (difficulties in identifying and describing emotion) is a transdiag-
nostic trait implicated in social–emotional and mental health problems in the general popu-
lation. Many autistic individuals experience significant social-communication difficulties and
elevated anxiety/depression and alexithymia. Nevertheless, the role of alexithymia in explain-
ing individual variability in the quality/severity of social-communication difficulties and/or
anxiety and depression symptoms in autism remains poorly understood.
Methods. In total, 337 adolescents and adults (autism N = 179) were assessed for alexithymia
on the Toronto Alexithymia Scale and for social-communication difficulties, anxiety and
depression symptoms. A total of 135 individuals (autism N = 76) were followed up 12–24
months later. We used regression models to establish cross-sectional and longitudinal associa-
tions between alexithymia, social-communication difficulties, anxiety and depression
symptoms.
Results. Autistic individuals reported significantly higher alexithymia than comparison indi-
viduals ( p < 0.001, r effect size = 0.48), with 47.3% of autistic females and 21.0% of autistic
males meeting cut-off for clinically relevant alexithymia (score ⩾61). Difficulties in describing
feelings were particularly associated with current self-reported social-communication difficul-
ties [ p < 0.001, β = 0.57, 95% confidence interval (CI) 0.44–0.67] and predicted later social-
communication difficulties ( p = 0.02, β = 0.43, 95% CI 0.07–0.82). Difficulties in identifying
feelings were particularly associated with current anxiety symptom severity ( p < 0.001,
β = 0.54, 95% CI 0.41–0.77) and predicted later anxiety ( p = 0.01; β = 0.31, 95% CI 0.08–0.62).
Conclusions. Our findings suggest that difficulties in identifying v. describing emotion are
associated with differential clinical outcomes in autism. Psychological therapies targeting
emotional awareness may improve social-communication and anxiety symptoms in autism,
potentially conferring long-term benefits.
Introduction
Background
Alexithymia, literally translated as ‘no words for emotions’, is a subclinical trait with an esti-
mated prevalence of 10% in the general population (Berthoz & Wessa, 2011; Nemiah,
Freyberger, & Sifneos, 1976). The construct of alexithymia can be broken down into several
facets, including: difficulties in identifying feelings (internally interpreting and differentiating
emotions); difficulties in describing feelings (expressing emotions) and externally oriented
thinking (focusing attention away from emotions; Bagby, Parker, and Taylor, 1994).
Of note, individuals with high-alexithymic traits are reported to experience significantly
more interpersonal difficulties and mental health problems than those with lower levels of
alexithymia (Grabe, Spitzer, & Freyberger, 2004; Spitzer, Siebel-Jürges, Barnow, Grabe, &
Freyberger, 2005; Vanheule, Desmet, Meganck, & Bogaerts, 2007). Furthermore, alexithymia
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has been shown to be a significant barrier to intervention success
across psychiatry and healthcare (Grabe et al., 2008; Ogrodniczuk,
Piper, & Joyce, 2011). In light of these issues, poor self-knowledge
of one’s internal emotions (i.e. alexithymia) is now recognised as a
transdiagnostic mechanism that modulates mental health out-
comes in the general population (Fernandez, Jazaieri, & Gross,
2016; National Institute of Mental Health, 2019).
Alexithymia and social-communication difficulties in autism
Given its intrinsic role in social–emotional processing, it is unsur-
prising that elevated rates of alexithymia have been reported
across a range of neurodevelopmental and neuropsychiatric con-
ditions that affect social and/or emotion understanding
(Berthoz, Pouga, & Wessa, 2011; Bird and Cook, 2013). For
example, current estimates suggest that at least 40–65% of autistic
people experience severe alexithymia (Bird & Cook, 2013; Hobson
et al., 2020; Kinnaird, Stewart, & Tchanturia, 2019). Autism is one
of the most common, lifelong neurodevelopmental conditions,
with a prevalence of ∼1.9% (Maenner et al., 2020) – characterised
by core traits of social-communication difficulties and restricted
and repetitive behaviours (American Psychiatric Association,
2013). In addition, some autistic individuals experience difficul-
ties with emotion awareness and processing. For instance, when
recounting personal memories, individuals may tend to focus
on objective events, rather than their feelings about those events
(Hurlburt, Happé, & Frith, 1994). Similarly, when reflecting on
internal emotions (e.g. when asked ‘how do you know when
you are happy?’), some autistic individuals consider the observ-
able features of emotions (‘because I am laughing’, ‘because it’s
my birthday’), over their subjective ‘feeling’ (Rieffe, Meerum
Terwogt, & Kotronopoulou, 2007).
Since social-communication difficulties are a core feature of
autism, most published studies have focused on associations
between alexithymia and difficulties in perceiving and under-
standing the emotions of others. For example, autistic individuals
with higher alexithymic traits experience more difficulties in
recognising verbal and non-verbal emotional expressions, com-
pared to those with lower levels of alexithymia (Cook, Brewer,
Shah, & Bird, 2013; Heaton et al., 2012; Oakley, Brewer, Bird, &
Catmur, 2016) – and these difficulties are associated with every-
day social functioning (Trevisan & Birmingham, 2016).
Furthermore, alexithymia in autism has been shown to relate
to reductions and/or differences in the production of emotion
expressions (Trevisan, Bowering, & Birmingham, 2016; Wagner
& Lee, 2008) and emotional empathy towards others (Bird
et al., 2010). These skills are critical for accurately interpreting
and appropriately responding to social cues and facilitating suc-
cessful interpersonal relationships (Ekman, 1999) and may, there-
fore, contribute to increased difficulties in social interactions.
Thus, findings to date imply that alexithymia may act as a modi-
fier, exacerbating social-communication difficulties in autism
(Mundy, Henderson, Inge, & Coman, 2007).
Alexithymia and anxiety/depression symptoms in autism
However, far fewer studies have considered the role of alexithymia
– particularly difficulties in perceiving one’s own emotions – in
explaining individual variability in anxiety and depression symp-
tom severity in autism. This is despite evidence that difficulties
with emotion awareness relate to mental health symptoms in
the general population (Mattila et al., 2008), including young
children (Rieffe, Oosterveld, Miers, Meerum Terwogt, & Ly,
2008). Moreover, at least 20–50% of autistic individuals experi-
ence co-occurring anxiety and/or depression – far higher rates
than those observed in the general population (Hollocks, Lerh,
Magiati, Meiser-Stedman, & Brugha, 2019; Simonoff et al.,
2008). Hence, research on mechanisms associated with
co-occurring anxiety and depression in autism has been declared
a research priority (Autistica, 2017; Pellicano, Dinsmore, &
Charman, 2014), for which alexithymia may provide a tractable
treatment target.
Some recent studies indicate that there may be associations
between alexithymia and anxiety/depression symptoms in autism.
For instance, Milosavljevic et al. (2016) showed that adolescents
with autism and elevated alexithymia self-reported significantly
higher concurrent anxiety than those with autism only.
Similarly, alexithymia has been found to partially mediate associa-
tions between core autism traits and anxiety and depression
symptoms in autistic young adults (Maisel et al., 2016; Morie,
Jackson, Wei, Marc, & Dritschel, 2019). These findings imply
that alexithymia may be a key contributing factor for mental
health problems in autism, as in the general population.
Nevertheless, there is a considerable lack of longitudinal
research examining the putative impact of alexithymia in autism
(Kojima, 2012). Existing studies have been cross-sectional in
nature and considered alexithymia as a unitary construct, when
there may be subtle differences between its individual facets
(e.g. difficulties in describing v. identifying emotions) and specific
outcomes. As a result, the role of alexithymia (or its individual
facets) in predicting the development of social-communication
difficulties and/or mental health symptoms remains unclear.
For example, alexithymia may be a modifying factor that inter-
acts with concurrent core autism traits and/or anxiety and depres-
sion symptoms, resulting in individual differences in outcome, or
treatment response. Additionally, or alternatively, alexithymia
may represent a precursor to later developing socio-emotional
and mental health problems – potentially via difficulties with
emotion perception/production (Brewer et al., 2016a; Trevisan
& Birmingham, 2016), interoception (perception of internal bod-
ily states; Garfinkel et al., 2016) and/or emotion regulation
(Maisel et al. 2016; Morie et al. 2019). Finally, alexithymia may
be a consequence of difficulties in understanding others’ emotions
(Carruthers, 2009), or act as a compensatory buffer against aver-
sive internalising problems (Kojima, 2012; Mor & Winquist,
2002). Overall, establishing longitudinal relationships between
potential precursors (e.g. alexithymia) and outcomes over time
(e.g. social functioning, anxiety and depression) is essential for
informing early and effective interventions and support in autism.
The current study
Thus, our study first aimed to assess cross-sectional associations
between alexithymia (including its individual facets), social-
communication difficulties, anxiety and depression symptoms in
a large, well-characterised cohort of autistic and non-autistic
males and females, aged 12–30 years. Furthermore, we modelled
longitudinal associations between earlier alexithymia and subse-
quent social-communication difficulties, anxiety and depression
symptoms approximately 12–24 months later. Based on previous
literature, we predicted that increasing alexithymia would be asso-
ciated with elevated social-communication difficulties, anxiety
and depression symptoms in the autism group, at a single time-
point and longitudinally.
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Methods
Participants
The current study is based on data from the EU-
AIMS Longitudinal European Autism Project (LEAP). A detailed
description of the design and methodologies of LEAP are reported
elsewhere (Loth et al., 2017). Briefly, LEAP employed a case-
control design whereby males and females aged 6–30 years,
with and without a formal diagnosis of autism spectrum disorder
(ASD), were recruited simultaneously across seven European
study sites. Subsequently, the cohorts were followed up longitu-
dinally, after approximately 12–24 months. Participants were ini-
tially recruited via existing databases, schools and flyers; and those
with mild intellectual disability (IQ⩽ 75) were additionally
recruited through clinic contacts or support groups. Although
individuals with IQ ⩽ 75 were recruited to both ASD and com-
parison groups, we note that few met these criteria, partly due
to the reasonably demanding nature of the full LEAP protocol
and because some individuals believed to have mild intellectual
disability based on an initial screener scored above 75 on standar-
dised IQ measures (see Loth et al., 2017).
In total, 337 participants aged 12–30 years (ASD N = 179) with
available alexithymia data were included in this study. Table 1
shows participants’ characteristics on entry to the study (time-
point one; T1). A total of 135 individuals (ASD N = 76) were
able to be followed up approximately 12–24 months later (time-
point two; T2). T2 participant characteristics are shown in online
Supplementary Table S2.
On entry to the study, there were no significant differences
between autistic and comparison individuals in age ( p = 0.73,
r effect size = 0.02) nor sex ( p = 0.42, ϕ = 0.04). Autistic indivi-
duals had marginally lower average IQ than comparison indivi-
duals (p = 0.02, r = 0.13), although median scores were fairly
comparable between groups (ASD median = 105.15, IQR =
20.09; comparison median = 108.18, IQR = 18.50). Autistic indivi-
duals had significantly more core autism traits (T1: p < 0.001; r⩾
0.68; T2: p < 0.001; r⩾ 0.54) and higher mental health symptom
severity (T1: p < 0.001; r⩾ 0.41; T2: p < 0.001; r⩾ 0.34) than com-
parison individuals across all measures, at both timepoints.
Participants who were able to be followed up at T2 did not sig-
nificantly differ from non-returners on baseline age/sex ( p⩾
0.14), alexithymia ( p = 0.22), social-communication difficulties
( p⩾ 0.12), nor depression symptoms ( p = 0.36). Returners had
slightly higher IQ ( p = 0.01) and lower anxiety ( p = 0.05) and
repetitive behaviours than non-returners ( p = 0.02). Reasons for
loss to follow-up included: participants returning at T2 but not
completing the alexithymia measure; inability to make contact
with participants; and personal circumstances that made partici-
pants unable to visit at T2.
Materials and procedures
Alexithymia
See online Supplementary Table S1 for a summary of all mea-
sures. To index alexithymia, we administered the 20-item self-
report Toronto Alexithymia Scale (TAS-20; Bagby et al., 1994),
which has been previously validated for use in autism (Berthoz
& Hill, 2005). The TAS-20 results in a total score and three sub-
scales: difficulties in identifying feelings (I am often puzzled by
sensations in my body), difficulties in describing feelings (It is dif-
ficult for me to find the right words for my feelings) and externally
oriented thinking (I prefer to analyse my problems rather than just
describe them). As evident from these example items, one’s aware-
ness of their difficulties with emotions seems somewhat distinct
from one’s awareness that they are experiencing a positive or
adverse emotional state.
Higher scores indicate higher alexithymia, with scores ⩾61
indicating ‘severe’ (i.e. clinically relevant) alexithymia (Parker,
Taylor, & Bagby, 2003). Alexithymia was weakly associated with
verbal IQ – significant in the whole sample (rs = −0.24, p < 0.001)
and marginal in the ASD group (rs = −0.16, p = 0.03), suggesting
results were not wholly explained by difficulties in completing the
TAS due to individual differences in verbal ability.
Core autism traits
The clinical characteristics of the full LEAP cohort are reported
elsewhere (Charman et al., 2017). In the current study, social-
communication difficulties were measured using self- and
parent-report versions of the Social Responsiveness Scale-2nd
Edition (SRS-2; Constantino and Gruber, 2012). Higher scores
(sex-specific T-norms) indicate more difficulties. Repetitive beha-
viours were measured using the parent-report Repetitive
Behaviour Scale-Revised (RBS-R; Lam and Aman, 2007), with
higher scores indicating more repetitive behaviours.
Anxiety/depression symptoms
Beck’s Anxiety and Depression Inventories (Beck, Beck, Jolly, &
Steer, 2005; Beck, Epstein, Brown, & Steer, 1988; Beck, Steer, &
Brown, 2001) were used to capture self-reported anxiety and
depression symptoms at two timepoints, ∼12–24 months apart.
Beck’s Inventories were chosen on the basis of their fast adminis-
tration time (reducing longitudinal participant burden) and abil-
ity to accurately screen for mental health problems in general
population and autism samples (Cassidy, Bradley, Bowen,
Wigham, & Rodgers, 2018; Leyfer, Ruberg, & Woodruff-Borden,
2006). We administered a youth-version for ages 12–17 years
and an adult-version for ages 18–30 years. Therefore, scores
were z-transformed for comparability, with higher scores indicat-
ing more severe symptoms.
Statistical analyses
Analyses were performed using RStudio®. As some data violated
the normality assumption, non-parametric analyses were used
for group comparisons (Mann–Whitney) and correlations
(Spearman’s rs). For group comparisons, effect size r (calculated
as Z/√N) is reported, with 0.10 denoting a small effect, 0.30 a
moderate effect and 0.50 a large effect. Bonferroni correction
was applied throughout. See Supplementary Table S3 for correla-
tions between all T1 and T2 measures.
To investigate cross-sectional associations between alexithy-
mia, and clinical features of social-communication difficulties,
anxiety and depression symptoms, we first compared those who
did v. did not meet cut-off (⩾61) for clinically relevant alexithy-
mia – an approach that would also capture potentially non-linear
relationships. Next, we investigated both cross-sectional and
longitudinal relationships between alexithymia and clinical
features in greater depth using linear (‘lm’) regression models.
Dependent variables were, respectively, SRS-2-rated social-
communication difficulties and Beck-rated anxiety/depression
symptom. Independent variables across all models were age, IQ,
sex and alexithymia (total/subscale scores).
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Table 1. Descriptives and group comparisons for participant characteristics and alexithymia at T1
(a) Demographic/
clinical
ASD (T1) Non-ASD (T1) Group comparison
N Median (IQR) Range N Median (IQR) Range χ2 (df, N) p ϕ
Sex: males (females) 124 (55) – – 103 (55) – – 0.64 (1,337) 0.42 0.04
Z p r effect size
Age (years) 179 19.57 (7.49) 12–30 158 19.11 (7.00) 12–30 0.35 0.73 0.02
Full-scale IQ 179 105.15 (20.09) 67–148 158 108.18 (18.50) 74–142 2.37 0.02* 0.13
SRS-2 (Self) 173 63.00 (13.00) 40–94 146 46.00 (7.00) 37–69 12.66 <0.001*** 0.71
SRS-2 (Parent) 142 68.50 (18.00) 43–95 64 43.50 (7.00) 37–73 10.40 <0.001*** 0.72
RBS-R 147 11.00 (14.50) 0–90 64 0.00 (1.00) 0–13 9.89 <0.001*** 0.68
Beck’s Anxiety 168 0.16a (1.32) −1.28 to 4.65a 150 −0.60a (0.72) −1.28 to 1.88a 7.35 <0.001*** 0.41
Beck’s Depression 168 0.05a (1.37) −0.97 to 4.15a 149 −0.65a (0.55) −1.08 to 2.16a 8.00 <0.001*** 0.45
(b) Alexithymia
ASD (T1) Non-ASD (T1) Group comparison
N Median (IQR) Range N Median (IQR) Range Z p r effect size
TAS total 179 52.00 (17.00) 24–88 158 40.00 (14.75) 20–69 8.85 <0.001*** 0.48
TAS identify 179 15.00 (10.00) 7–35 158 9.00 (6.00) 7–30 8.05 <0.001*** 0.44
TAS describe 179 16.00 (7.00) 5–25 158 10.00 (5.00) 5–24 8.21 <0.001*** 0.45
TAS external 179 22.00 (6.00) 8–40 158 20.00 (7.00) 8–35 4.04 <0.001*** 0.22
SRS-2, Social Responsiveness Scale-Second Edition; RBS-R, Repetitive Behaviour Scale-Revised; TAS, Toronto Alexithymia Scale; IQR, interquartile range; Z, statistic for Mann–Whitney comparison; χ2(df, N ), χ
2 test (degrees of freedom, number of
participants); r, effect size (Z/√N ).
aScores z-transformed for comparability between youth and adult versions.
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Results
Alexithymia in the current sample
Autistic individuals reported, on average, significantly higher total
alexithymia than comparison individuals, with a moderate effect
size ( p < 0.001, r = 0.48). Autistic individuals scored significantly
higher than comparison individuals across TAS-20 subscales, par-
ticularly difficulties in identifying ( p < 0.001, r = 0.44) and
describing emotion ( p < 0.001, r = 0.45; Table 1).
As demonstrated in Fig. 1, 29.1% (N = 52) of autistic indivi-
duals met cut-off for clinically relevant alexithymia (score ⩾61;
Parker et al., 2003), compared to 4.4% (N = 7) of comparison in-
dividuals. Autistic females were over-represented in the group
who met cut-off ( p = 0.001, χ2(1179) = 11.55, ϕ = 0.27). A total of
47.3% (N = 26) of autistic females met cut-off, compared to
21.0% (N = 26) of males. Autistic females in our sample also
scored higher than males for self-reported social-communication
difficulties ( p = 0.01, r = 0.20). Conversely, there was no sig-
nificant sex difference in alexithymia in the comparison group
(p = 0.96, χ2(1158) = 0.003, ϕ = 0.04).
T1 associations between alexithymia and
social-communication difficulties
First, we used a categorical approach to confirm that individuals
with clinically relevant alexithymia scored higher for social-
communication difficulties than those with lower levels of alex-
ithymia (see online Supplementary Table S4). Overall, individuals
who met cut-off for severe alexithymia had significantly higher
SRS-2 self-reported social-communication difficulties ( p < 0.001,
r = 0.55) and, to a lesser degree, parent-reported social-
communication difficulties ( p < 0.001, r = 0.33) than those
with lower levels of alexithymia. Similarly, in the ASD group,
individuals with severe alexithymia scored high for SRS-2 self-
( p < 0.001, r = 0.61) and parent-reported social-communication
difficulties ( p = 0.01, r = 0.22).
Next, we considered dimensional relationships between alex-
ithymia (sub)scale scores and social-communication difficulties,
controlling for potential confounds of age, IQ, sex and concurrent
repetitive behaviours. In the whole sample, alexithymia remained
significantly associated with SRS-2 self-reported social-
communication difficulties, across all TAS-20 (sub)scales, with
the strongest effect size for difficulties in describing feelings:
total ( p < 0.001, β = 0.62, 95% confidence interval (CI) 0.52–
0.69), identify ( p < 0.001, β = 0.53, 95% CI 0.40–0.59), describe
( p < 0.001, β = 0.57, 95% CI 0.46–0.64) and external ( p < 0.001,
β = 0.28, 95% CI 0.16–0.38). Difficulty in describing feelings
was also significantly related to SRS-2 parent-reported social-
communication difficulties ( p = 0.001, β = 0.19, 95% CI 0.08–
0.29).
In the ASD group, alexithymia remained significantly associated
with SRS-2 self- (but not parent-) reported social-communication
difficulties, across all TAS-20 (sub)scales, with the strongest
effect size for difficulties in describing feelings: total ( p < 0.001,
β = 0.64, 95% CI 0.51–0.73), identify ( p < 0.001, β = 0.52, 95% CI
0.37–0.62), describe ( p < 0.001, β = 0.57, 95% CI 0.44–0.67) and
external ( p = 0.001, β = 0.25, 95% CI 0.10–0.38).
T1 associations between alexithymia and anxiety/
depression symptoms
Similar to the findings reported above, individuals who met cut-
off for severe alexithymia had significantly higher T1 Beck-rated
anxiety and depression symptom severity, as compared to those
with lower levels of alexithymia – in the whole sample ( p <
0.001, r⩾ 0.42) and ASD group ( p < 0.001, r⩾ 0.46; online
Supplementary Table S4).
Once again, we assessed dimensional relationships between
alexithymia and anxiety/depression symptoms, controlling for
potential confounds of age, IQ, sex and core autism traits. Based
on findings from simple correlations (online Supplementary
Table S3), we ran linear regression models for associations between
all alexithymia (sub)scale scores, except for externally oriented
thinking.
As shown in Table 2, difficulties in identifying feelings were
significantly associated with anxiety symptom severity in the
whole sample ( p < 0.001, β = 0.54, 95% CI 0.41–0.69). Of note,
when depression symptoms were also controlled for, the relation-
ship between difficulties in identifying feelings and anxiety
remained ( p < 0.001, β = 0.28, 95% CI 0.15–0.40). The same pat-
tern of effects was identified in the ASD group. Difficulties in
identifying feelings accounted for significant variance in anxiety
symptoms ( p < 0.001, β = 0.54, 95% CI 0.41–0.77), even after con-
trolling for depression ( p = 0.001, β = 0.27, 95% CI 0.12–0.46).
In contrast, although difficulties in identifying feelings
were also significantly associated with depression in the whole
Fig. 1. Box plots showing median and IQR of total alexithy-
mia in ASD and comparison groups, split by sex. Individual
data plots are overlaid to demonstrate the variability of
scores in both groups. Cut-off for severe alexithymia (⩾61)
is indicated by the dashed line.
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Table 2. Regression coefficients and model fit statistics for T1 Beck-rated anxiety and depression symptom severity, regressed onto alexithymia scores, controlling for demographic factors and core autism traits in the: (a) whole sample; (b)
ASD group
(a) All (b) ASD
Beck’s Anxiety (T1) Beck’s Depression (T1) Beck’s Anxiety (T1) Beck’s Depression (T1)
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Model 1 Demographic Age −0.08 (−0.22 to 0.04) −0.15 (−0.29 to −0.03)* −0.05 (−0.23 to 0.11) −0.15 (−0.34 to 0.01)
IQ −0.10 (−0.22 to 0.01) −0.02 (−0.14 to 0.10) −0.18 (−0.35 to −0.04)* −0.07 (−0.24 to 0.09)
Sex −0.12 (−0.26 to −0.01)* −0.13 (−0.27 to −0.02)* −0.08 (−0.28 to 0.08) −0.11 (−0.31 to 0.05)
Autism traits SRS-2 0.45 (0.27–0.70)*** 0.53 (0.35–0.78)*** 0.39 (0.19–0.71)*** 0.38 (0.16–0.71)**
RBS-R 0.03 (−0.11 to 0.18) −0.09 (−0.24 to 0.05) 0.06 (−0.12 to 0.25) −0.10 (−0.30 to 0.08)
Alexithymia Total 0.21 (0.04–0.41)* 0.20 (0.02–0.39)* 0.18 (−0.04 to 0.44) 0.22 (−0.01 to 0.49)
Model fit (R2adj) F(6,191) = 23.58, p < 0.001***, ηp
2 = 0.64 (40.8%) F(6,189) = 21.34, p < 0.001***, ηp
2 = 0.63 (38.5%) F(6,130) = 12.64, p < 0.001***, ηp
2 = 0.61 (33.9%) F(6,128) = 9.58, p < 0.001, ηp
2 = 0.59 (27.8%)
Model 2 Demographic Age −0.15 (−0.28 to −0.05)** −0.21 (-0.35 to −0.11)*** −0.13 (−0.30 to 0.01) −0.22 (−0.41 to −0.08)**
IQ −0.09 (−0.19 to 0.01) −0.01 (−0.12 to 0.09) −0.16 (−0.32 to −0.04)** −0.06 (−0.21 to 0.08)
Sex −0.05 (−0.16 to 0.06) −0.07 (−0.19 to 0.04) −0.02 (−0.18 to 0.14) −0.04 (−0.22 to 0.11)
Autism traits SRS-2 0.26 (0.11–0.44)*** 0.37 (0.22–0.57)*** 0.21 (0.05–0.44)** 0.24 (0.06–0.49)**
RBS-R 0.04 (−0.09 to 0.17) −0.08 (−0.23 to 0.04) 0.05 (−0.10 to 0.22) −0.10 (−0.29 to 0.05)
Alexithymia Identify 0.54 (0.41–0.69)*** 0.48 (0.34–0.63)*** 0.54 (0.41–0.77)*** 0.52 (0.36–0.74)***
Model fit (R2adj) F(6,191) = 39.32, p < 0.001***, ηp
2 = 0.69 (53.9%) F(6,189) = 31.96, p < 0.001***, ηp
2 = 0.67 (48.8%) F(6,130) = 22.70, p < 0.001***, ηp
2 = 0.67 (48.9%) F(6,128) = 16.49, p < 0.001***, ηp
2 = 0.64 (41.0%)
Model 3 Demographic Age −0.10 (−0.24 to 0.03) −0.16 (−0.31 to −0.04)** −0.06 (−0.24 to 0.11) −0.15 (−0.35 to 0.01)
IQ −0.12 (−0.24 to −0.01)* −0.04 (−0.16 to 0.07) −0.20 (−0.37 to −0.06)** −0.10 (−0.27 to 0.06)
Sex −0.12 (−0.27 to −0.01)* −0.13 (−0.28 to −0.02)* −0.08 (−0.28 to 0.08) −0.11 (−0.31 to 0.06)
Autism traits SRS-2 0.63 (0.48–0.88)*** 0.71 (0.56–0.97)*** 0.60 (0.44–0.93)*** 0.60 (0.43–0.95)***
RBS-R 0.02 (−0.12 to 0.17) −0.10 (−0.26 to 0.04) 0.05 (−0.13 to 0.24) −0.10 (−0.30 to 0.07)
Alexithymia Describe −0.01 (−0.18 to 0.16) −0.03 (−0.21 to 0.14) −0.10 (−0.34 to 0.10) −0.08 (−0.32 to 0.14)
Model fit (R2adj) F(6,191) = 21.98, p < 0.001***, ηp
2 = 0.63 (39.0%) F(6,189) = 20.07, p < 0.001***, ηp
2 = 0.62 (37.0%) F(6,130) = 12.21, p < 0.001***, ηp
2 = 0.61 (33.1%) F(6,128) = 8.86, p < 0.001***, ηp
2 = 0.59 (26.0%)
T1, timepoint 1; SRS-2, Social Responsiveness Scale-Second Edition (self-report); RBS-R, Repetitive Behaviour Scale-Revised; β (95% CI), regression coefficient with 95% confidence intervals.
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sample ( p < 0.001, β = 0.48, 95% CI 0.34–0.63), this association
fell to the marginal level for significance after controlling for anx-
iety ( p = 0.04, β = 0.14, 95% CI 0.01–0.28). Similarly, in the ASD
group, difficulties in identifying feelings were significantly asso-
ciated with depression symptoms ( p < 0.001, β = 0.52, 95% CI
0.36–0.74), but marginally after controlling for anxiety ( p = 0.03,
β = 0.19, 95% CI 0.02–0.38).
Post-hoc analysis using the ‘mediate’ function (10 000 itera-
tions) showed that anxiety partly mediated associations between
difficulties in identifying feelings and depression. a denotes the
path from difficulty in identifying feelings to anxiety; b is the
path from anxiety to depression symptoms and c′ is the direct
path from difficulty in identifying feelings to depression.
Although the direct path from difficulty in identifying feelings to
depression remained (whole sample c′ = 0.04, S.E. = 0.01, p < 0.001;
ASD c′ = 0.04, S.E. = 0.01, p < 0.001), anxiety was a significant, par-
tial mediator of this relationship (whole sample a = 0.10, S.E. = 0.01,
p < 0.001; b = 0.62, S.E. = 0.04, p < 0.001; ASD a = 0.10, S.E. = 0.01,
p < 0.001; b = 0.58, S.E. = 0.06, p < 0.001).
Longitudinal associations between alexithymia,
social-communication difficulties, anxiety and depression
symptoms
Stability in measures over time
For those who participated at both timepoints, paired difference
tests showed that, at the group level, alexithymia severity did
not significantly change over time ( p = 0.60, r = 0.05). Similarly,
there was no significant change in self-reported social-
communication difficulties ( p = 0.17, r = 0.18), anxiety ( p = 0.08,
r = 0.15), nor depression symptoms ( p = 0.10, r = 0.14).
These effects were consistent when considering the ASD group
only (alexithymia: p = 0.47, r = 0.08; social-communication:
p = 0.22, r = 0.22; anxiety: p = 0.48, r = 0.08; depression: p = 0.20,
r = 0.15; see Table 1 and online Supplementary Table S2 for
descriptives). At the individual level, fewer than half of autistic
participants exhibited a minimally clinically important change
of >0.5 S.D. on any variable, between timepoints (see Norman,
Sloan, and Wyrwich, 2003). Individual longitudinal trajectories
for alexithymia, social-communication difficulties, anxiety and
depression are shown in Fig. 2.
Social-communication difficulties
To ascertain whether earlier alexithymia was associated with later
self-reported social-communication difficulties, anxiety and
depression symptoms, over ∼12–24 months, we conducted longi-
tudinal regression analyses (Fig. 3).
In the whole sample, no associations between alexithymia and
social-communication difficulties were maintained longitudinally.
Conversely, in the ASD group, T1 total alexithymia remained
marginally associated with T2 self-reported social-
communication difficulties, after controlling for age, IQ, sex,
repetitive behaviours and T1 self-reported social-communication
difficulties ( p = 0.02, β = 0.52, 95% CI 0.09–0.92). The same was
true for the association between T1 difficulties in describing
feelings and T2 self-reported social-communication difficulties
( p = 0.02, β = 0.43, 95% CI 0.07–0.82), although we caution that
only N = 22 autistic individuals had sufficient longitudinal data.
Fig. 2. Individual trajectories of alexithymia, self-reported social-communication difficulties, anxiety and depression from T1 to T2 for autistic individuals in our
cohort. Few individuals experienced ‘minimally clinically important’ change (>0.5 S.D. from baseline score): total alexithymia N = 13 ‘worsen’, N = 20 ‘improve’,
N = 43 ‘same’; self-reported social-communication difficulties N = 5 ‘worsen’, N = 4 ‘improve’, N = 22 ‘same’; anxiety N = 13 ‘worsen’, N = 9 ‘improve’, N = 48
‘same’; depression N = 16 ‘worsen’, N = 11 ‘improve’, N = 44 ‘same’.
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Overall both models were significant and accounted for over
59.0% of the variance in T2 self-reported social-communication
difficulties in the ASD group (total F(6,22) = 8.01, p < 0.001, ηp
2 =




T1 difficulty in identifying feelings remained associated with T2
anxiety symptoms in individuals with sufficient longitudinal
data from both the whole sample (N = 76; p = 0.002, β = 0.32,
95% CI 0.12–0.52) and ASD group (N = 51; p = 0.01, β = 0.31,
95% CI 0.08–0.62), after accounting for demographic factors,
core autism traits and T1 anxiety/depression symptoms. The
overall model for this association was significant and accounted
for over 69.0% of the variance in T2 anxiety symptom severity
(whole sample F(8,76) = 26.43, p < 0.001, ηp
2 = 0.79 R2adj = 70.8%;
ASD F(8,51) = 17.86, p < 0.001, ηp
2 = 0.79 R2adj = 69.6%).
No other longitudinal models showed significant associations
between T1 alexithymia and T2 anxiety/depression symptoms,
after controlling for other factors. Nevertheless, in simple correlations,
T1 difficulties in identifying feelings remained associated with
T2 depression (whole sample: rs = 0.47, p < 0.001; ASD: rs = 0.51,
p < 0.001; Supplementary Table S3).
Discussion
Alexithymia and social-communication difficulties in autism
To our best knowledge, this is the most comprehensive study to
date to assess cross-sectional – and the first to assess longitudinal
– associations between alexithymia, social-communication diffi-
culties, anxiety and depression symptoms in autistic males and
females, during adolescence and early adulthood. First, we
found that all facets of alexithymia (total severity, difficulties in
identifying/describing feelings and externally oriented thinking)
were significantly associated with concurrent self- (but not
parent-) reported social-communication difficulties in autism.
The strongest associations were between total alexithymia/diffi-
culties in describing feelings and self-reported social-
communication difficulties. Furthermore, associations between
both total alexithymia and difficulties in describing feelings
with self-reported social-communication difficulties were main-
tained longitudinally (albeit in a smaller subsample for whom
data were available), and this was true even after controlling for
age, IQ, sex, repetitive behaviours and earlier T1 social-
communication difficulties.
This finding suggests that autistic individuals with lower emo-
tional awareness, particularly those who find it challenging to
describe their emotions, also perceive themselves to experience
more interpersonal difficulties – although these difficulties may
not be observed by others. This corresponds to previous findings
from individuals with high alexithymia without autism (and ana-
lyses including the comparison group in this study), for whom
difficulties with describing feelings are also the facet of alexithy-
mia most strongly associated with interpersonal problems
(Spitzer et al., 2005).
One possible explanation for the observed associations
between alexithymia and social-communication difficulties is
that difficulties with emotion recognition and production disrupt
everyday social interactions (Bothe, Palermo, Rhodes, Burton, &
Fig. 3. Scatterplots with regression lines fitted, showing longitudinal relationships between T1 alexithymia and T2 self-reported social-communication difficulties
and anxiety symptoms.
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Jeffery, 2019; Trevisan & Birmingham, 2016). For instance, previ-
ous studies suggest some autistic individuals find it challenging to
interpret others’ facial emotion expressions; and non-autistic indi-
viduals experience difficulties in interpreting the expressions of
autistic people (Brewer et al., 2016a; Loth, Ahmad, Watson,
Duff, & Duchaine, 2018). Furthermore, given that difficulty in
describing feelings was the alexithymia subscale most strongly
related to social-communication difficulties, it is likely that
broader (emotional) language impairments may be implicated
(Lartseva, Dijkstra, & Buitelaar, 2015). Indeed, in the current
study, verbal ability was significantly (although weakly) associated
with alexithymia in both the whole sample and autism group. In
the wider literature, ‘acquired’ alexithymia has been reported fol-
lowing traumatic brain injury affecting language regions (Hobson
et al., 2018) and language delay/reduced depth of verbal expres-
sion are common in autism – observed from early development
(Baird et al., 2006; Rieffe et al., 2007).
Nevertheless, since alexithymia was associated with self- but
not parent-reported social difficulties in the autism group, it is
also possible that some autistic individuals are highly aware of
the impact of their emotional understanding on interpersonal
relationships and experience low confidence in their social abil-
ities. For example, difficulties in recognising the emotions and
thoughts of others may lead to real-world negative social encoun-
ters or ‘catastrophising’ negative beliefs (e.g. ‘they must be upset
with me’), which increase self-consciousness in future social inter-
actions (Capriola, Maddox, & White, 2017; Spain, Sin, &
Freeman, 2016; van Roekel, Scholte, & Didden, 2010).
Therefore, interventions for improving social communication in
autism should not only focus on social skills, but also on emo-
tional awareness. This may have wider benefits for improving sub-
jective perceptions of social competence, reducing social anxieties
and increasing confidence in social settings.
Difficulties in identifying feelings and anxiety/depression
symptoms in autism
In addition, difficulties in identifying feelings were significantly
and robustly associated with anxiety symptoms in autistic adoles-
cents and adults – even after controlling for demographic factors,
core autism traits and concurrent depression. Moreover, using
longitudinal data, we ascertained that earlier difficulties in identi-
fying feelings remained associated with anxiety symptoms
approximately 12–24 months later, also after accounting for earl-
ier T1 anxiety. Since alexithymia and anxiety were stable over
time in over half of autistic individuals in this sample, findings
suggest that the ability to accurately interpret one’s own emo-
tional state has a significant and persistent impact on mental
health outcomes in autism. Overall, our findings lend support
to the suggestion that, as progress is made in developing and
modifying interventions for autistic people, the potentially pri-
mary role of emotional awareness must be considered (Conner
et al., 2019).
The reported findings have wider implications for informing
early intervention strategies to improve mental health outcomes
in autism. Currently, cognitive behavioural therapy (CBT) is the
most widely supported intervention for anxiety in autism
(White et al., 2018). Similar to many psychological therapies,
this approach requires individuals to reflect on and discuss emo-
tions and their antecedents. Yet, paradoxically, autistic individuals
with particularly low emotional awareness are the most likely to
be referred for CBT (likely due to associated mental health
problems; Roberts-Collins, Mahoney-Davies, Russell, Booth, and
Loades, 2018). This raises several questions around the long-term
effectiveness of current treatment approaches and highlights the
stark need for additional research to develop and evaluate treat-
ment modifications for managing mental health symptoms in
autism (Walters, Loades, & Russell, 2016). Notably, emotion rec-
ognition training is included in current guidance from the UK
National Institute for Health and Care Excellence on the adapta-
tion of CBT for autism (National Institute of Health & Care
Excellence, 2013), for which this study provides empirical
support.
A key direction for future research is, therefore, to assess
whether incorporating techniques specifically targeting emotional
awareness could improve therapeutic outcomes for autistic people.
For instance, psychological interventions that specifically target,
rather than passively measure, alexithymia have been found to
be successful in reducing alexithymic traits and improving emo-
tion regulation skills in neurotypical populations (Cameron,
Ogrodniczuk, & Hadjipavlou, 2014). Such methods have tended
to focus on psychoeducation and stress-management. However,
the efficacy of these techniques for improving outcome in autism,
and other neurodevelopmental/neuropsychiatric conditions char-
acterised by high rates of alexithymia, is yet to be confirmed
(Cooper, Loades, & Russell, 2018).
Another outstanding issue for future research is to establish
the mechanistic processes that connect emotional awareness and
mental health outcomes (e.g. anxiety) over time. Emotion regula-
tion difficulties are one candidate underpinning mechanism for
mental health gaining increasing attention in the autism literature
(Cai, Richdale, Uljarević, Dissanayake, & Samson, 2018), with
emotion awareness argued to be the first and most fundamental
aspect of successful emotion regulation (Gross, 2015). For
instance, if the accurate identification of one’s current emotion
is impeded, this may hinder the implementation of adaptive emo-
tion regulation strategies, including cognitive reappraisal (reinter-
preting the emotion) and situation selection/modification
(adjusting the environment; Gross and Thompson, 2007).
Adaptive emotion regulation may also be impeded by broader
difficulties in interpreting internal bodily states (i.e. interoception)
that indicate heightened arousal or anxiety, such as elevated heart
and breathing rate (Garfinkel, Eccles, & Critchley, 2015; Müller
et al., 2015). Of note, the Beck’s Anxiety Inventory indexes several
physiological anxiety symptoms (heart/breathing rate and trem-
bling) and some previous studies suggest that alexithymia is
related to general interoceptive impairments, across affective
and non-affective domains (Brewer, Cook, & Bird, 2016b;
Murphy, Catmur, & Bird, 2018). Furthermore, alongside alexithy-
mia, autistic individuals have been shown to experience elevated
interoception and emotion regulation difficulties – engaging in
fewer ‘voluntary’ (e.g. cognitive reappraisal – reinterpreting emo-
tional stimuli) and more ‘involuntary’ regulation strategies (e.g.
rumination and arousal) than neurotypical individuals (Gross,
2015; Mazefsky, Borue, Day, & Minshew, 2014; Samson,
Hardan, Lee, Phillips, & Gross, 2015). Thus, difficulties with emo-
tional, and broader internal bodily, awareness may compromise
‘downstream’ emotion regulation processes, increasing vulnerabil-
ity for mental health problems such as anxiety.
Finally, we note that while relationships between difficulties in
identifying feelings and anxiety symptoms were robust, we iden-
tified a more complex pattern of results for depression.
Difficulties in identifying feelings and depression were associated
cross-sectionally, although associations fell to the marginal level
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for significance after also controlling for anxiety. In addition, after
accounting for other factors, earlier difficulties in identifying feel-
ings were not longitudinally associated with depression symptoms
12–24 months later, in the whole sample, nor the autism group.
This may suggest that associations between alexithymia and
depression symptoms are explained by wider shared factors,
such as co-occurring anxiety (Milosavljevic et al., 2016), or situ-
ational factors such as social withdrawal and loneliness (Hedley,
Uljarević, Foley, Richdale, & Trollor, 2018). In support of this sug-
gestion, a post-hoc mediation analysis showed that anxiety partly
mediated cross-sectional associations between difficulties in iden-
tifying feelings and depression.
Strengths and limitations
A major strength of our study is the inclusion of a heterogeneous,
well-characterised sample of autistic males and females, aged 12–
30 years. By including females, we were able to ascertain that sig-
nificantly more diagnosed autistic females than males report high
alexithymia. This implies that observed sex differences in rates of
co-occurring emotional symptoms in autism (i.e. higher rates of
anxiety/depression in autistic females; Mandy et al., 2012) may
be explained by sex differences in their underpinning mechan-
isms. Furthermore, to our best knowledge, this is the first study
to report longitudinal associations between alexithymia and
social-communication difficulties, anxiety and depression symp-
toms in autism. We were thus able to confirm that alexithymia
in our cohort was generally stable over a period of approximately
12–24 months, supporting the conceptualisation of alexithymia as
a trait, rather than state (Salminen, Saarijärvi, Ääirelä, &
Tamminen, 1994). However, we also acknowledge several
limitations.
First, although we report associations between alexithymia and
anxiety/depression symptoms for the whole sample (including the
comparison group), in addition to the autism group, these must
be interpreted with some caution. This is because clinically rele-
vant mental health symptoms were screened out in the compari-
son (but not ASD) group on recruitment. We chose to report
findings including our comparison group to address questions
pertaining to specificity. For instance, associations between alex-
ithymia and concurrent social-communication difficulties, as
well as between alexithymia and concurrent/later anxiety symp-
toms were consistent between the whole sample and autism
group. This adds to literature suggesting that the role of alexithy-
mia in relation to mental health outcomes is not specific to a sin-
gle neurodevelopmental/neuropsychiatric condition (e.g. autism),
but instead a broader, diagnostically cross-cutting mechanism for
mental health (National Institute of Mental Health, 2019).
Furthermore, our findings imply that there are likely significant
‘commonalities’ in the nature of underpinning risk factors for
mental health symptoms between autistic and neurotypical indi-
viduals, however they may differ in frequency/intensity.
Second, due to the lack of availability of self-report alexithymia
measures for children and individuals with intellectual disability
(Griffin, Lombardo, & Auyeung, 2016; Loas, Braun, Delhaye, &
Linkowski, 2017), we were only able to include autistic individuals
aged ⩾12 years, with IQ⩾ 67. This prevented us from assessing
whether associations between alexithymia and anxiety and
depression symptoms were consistent across developmental
stage and level and from generalising findings beyond the age
range of 12–30 years. Indeed, a longitudinal period of 12–24
months is a reasonably short window for capturing traits that
may have been established earlier in development. Therefore, a
prospective longitudinal approach will be beneficial for further
elucidating the mechanistic pathways linking alexithymia and
outcomes in autism. In relation to this point, we were unable to
assess the role of alexithymia in predicting change in social-
communication difficulties, anxiety and depression symptoms
between timepoints, due to the small number of participants
who significantly changed on these features within the study per-
iod. It is still notable that we were able to include autistic indivi-
duals from age 12, since early adolescence is the developmental
stage at which anxiety and depression symptoms most commonly
emerge for both autistic and non-autistic individuals (Kessler
et al., 2005; Simonoff et al., 2008). Nevertheless, the development
and validation of tools for indexing alexithymia in under-
represented groups is paramount (see Gaigg, Cornell, and Bird,
2016).
Conclusions
Alexithymia, and particularly difficulty in describing feelings, is
significantly associated with greater self-reported social-
communication difficulties in autism, both cross-sectionally and
longitudinally. Furthermore, difficulty in identifying feelings is
related to anxiety symptom severity, including over a longitudinal
period of at least 12–24 months. Taken together, these findings
show that the influence of alexithymia on social functioning
and anxiety is both substantial and persistent for autistic people
– and possibly for autistic girls and women in particular. This
has notable implications for intervention, indicating that psycho-
logical therapies targeting emotional awareness may improve later
outcomes for some individuals.
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